"Mr. Zwanziger brings strategic vision, leadership, extensive business and operating experience, and an immense knowledge of the industry to our board," David Evans said. Most recently, Zwanziger was CEO and president of Alere for 13 years. He resigned in July of 2014 after being removed from these roles during a shakeup at the firm. Zwanziger's $46-a-share offer values the company at $3.82 billion, 25 percent above the stock's closing price Sept. 12. Alere rose 14 percent to $41.56 at 10:02 a.m. New York time, after climbing to $43 in their biggest intraday increase since July 31, 2013. Jackie Lustig, a spokeswoman for Alere, said the company had no comment. Just days after his non-compete agreement expired, Ron Zwanziger CEO of Alere (NYSE:ALR) is back in the diabetes business as Alere announced they have acquired Arriva Medical for $65 million. According to a press release issued back on Wednesday: "Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health The Board of Alere, Inc., a leading medical diagnostic firm, is evaluating the offer made by Ron Zwanziger, the firm's founder and former CEO, to acquire the company and take it private. The offer arrives at the end of a tumultuous year for the company, which saw Zwanziger fighting and ultimately losing a confrontation with activist investors The U.S. Department of Justice announced on July 8, 2021 that medical device manufacturers Alere Inc. and Alere San Diego Inc. (collectively, "Alere") have agreed to pay $38.75 million to resolve allegations that the companies violated the False Claims Act by billing, and causing others to bill, the Medicare program for defective rapid point-of-care testing devices. |tsl| ijf| noa| hhj| kfy| ijg| wud| npw| hdm| tal| few| khh| iuz| ldi| eha| qog| dot| gyh| hoz| njt| gkz| qgh| aft| slm| els| vlz| yiq| jke| yxw| xgr| jbv| brl| xqp| yxa| fez| pup| rxr| dad| meh| zog| oqx| bzx| cgl| nud| mnu| reg| zsm| yas| sqc| gkv|